NSW Cannabis Medicines Advisory Service preliminary survey results - Enquirer perceptions and patient outcomes.
Myfanwy GrahamS BirdZ HowardM DobsonK PalazziC J LucasJ SchneiderK EagarJ H MartinPublished in: Internal medicine journal (2021)
Preliminary findings highlight the impact of an innovative cannabis medicines drug information service in supporting health professional clinical practice in an area of rapid knowledge translation. Quality assurance data indicates that the service is perceived well by the majority of enquirers. Patient outcomes data across a wide range of indications suggest some effectiveness and a reasonable safety profile for prescribed cannabis medicines for most patients. This article is protected by copyright. All rights reserved.
Keyphrases
- healthcare
- mental health
- end stage renal disease
- clinical practice
- electronic health record
- ejection fraction
- newly diagnosed
- big data
- chronic kidney disease
- health information
- randomized controlled trial
- public health
- depressive symptoms
- systematic review
- physical activity
- peritoneal dialysis
- emergency department
- social support
- patient reported outcomes